Come on, Blue!

Despite the persistent strength in AMZN FB GOOGL, and a few others, the market may be tipping its hand as to how narrow it is when we see the likes of BLUE fail to sustain even a modest snapback rally from beaten-down conditions. 

Indeed, the bullish thesis on BLUE noted on this website last December has come and gone, with the stock's steep, momentum uptrend unraveling viciously in recent months. 

I recognize that news came out about the stock, namely the abstracts for the American Society of Hematology (ASH) meeting, which were released this morning.

But it drives home the point that the VRX weakness is not an entirely isolated case--Even strong setups like CRM reversed from impressive and enticing strength this morning, now flashing red. 

So we should know by tomorrow morning after the jobs report reaction whether bulls are playing  rope-a-dope in terms of the lack of broad market participation.